Skip to main content

Table 3 Ovarian stimulation outcomes based on the genotypes of the LHCGR gene in patients triggered with r-hCG and GnRH-a

From: Post-trigger luteinizing hormone concentration to positively predict oocyte yield in the antagonist protocol and its association with genetic variants of LHCGR

 

r-hCG trigger (n = 204)

P value

GnRH-a trigger (n = 167)

P value

Stimulation parameters and outcomes

GG genotype (n = 180)

AG Genotype (n = 24)

 

GG genotype (n = 140)

AG genotype (n = 27)

 

BMI

22.28 (2.89)

22.24 (3.25)

0.943

22.06 (3.09)

22.36 (3.21)

0.639

Days of gonadotrophin (d)

10.01 (1.69)

10.00 (1.38)

0.975

9.92 (1.48)

10.44 (1.83)

0.109

Total dose of gonadotrophin (IU)

1825.76 (709.98)

1727.08 (584.92)

0.515

1503.03 (497.47)

1692.13 (644.78)

0.088

Post-trigger hCG (LH) concentration (IU/L)

93.72 (30.83)

90.00 (39.95)

0.593

60.91 (28.37)

46.10 (15.70)

 < 0.001

ORR (× 100%)

0.99 (0.24)

0.98 (0.15)

0.674

0.96 (0.26)

0.85 (0.26)

0.042

MORR (× 100%)

0.84 (0.25)

0.82 (0.23)

0.683

0.79 (0.25)

0.69 (0.19)

0.042

Fertilization rate (× 100%)

0.71 (0.19)

0.73 (0.20)

0.521

0.72 (0.19)

0.71 (0.19)

0.775

No.of high-quality embryos (n)

3.55 (2.50)

4.21 (2.41)

0.224

6.89 (4.82)

5.26 (3.69)

0.053

  1. BMI Body mass index, ORR Oocyte retrieval rate, MORR Mature oocyte retrieval rate, r-hCG Recombinant human chorionic gonadotropin, GnRH-a Gonadotropin-releasing hormone agonists